Status:
COMPLETED
OSPM-Enhanced AI Model to Identify Premalignant and Malignant Ocular Surface Tumors
Lead Sponsor:
Ningbo Eye Hospital
Conditions:
Performance of the Model
Eligibility:
All Genders
1-100 years
Brief Summary
An OSPM-enhanced deep learning model has been developed for identifying premalignant and malignant tumors using data retrospectively collected from the Ningbo Eye Hospital, Jiangdong Eye Hospital, and...
Eligibility Criteria
Inclusion
- ● Ocular surface tumor images with histopathological findings
Exclusion
- ● Low-quality images
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06567028
Start Date
June 1 2024
End Date
November 1 2024
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ningbo Eye Hospital
Ningbo, Zhejiang, China, 315040